The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
TREM-1 upregulation as a potential predictive immune biomarker of pathologic complete response (pCR) in patients (pts) with triple-negative breast cancer (TNBC) receiving neoadjuvant therapy (NAT).
 
Albert Jang
Honoraria - RealTimeCase
 
Nickolas Stabellini
No Relationships to Disclose
 
Nerea Lopetegui-Lia
No Relationships to Disclose
 
Mona Patel
No Relationships to Disclose
 
Megan Kruse
Honoraria - Curio Science
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo; GE Healthcare; Genentech; Gilead Sciences
Research Funding - AstraZeneca (Inst)
(OPTIONAL) Uncompensated Relationships - Lilly
 
Pat Rayman
No Relationships to Disclose
 
Paul Pavicic
No Relationships to Disclose
 
Alberto Montero
Honoraria - AstraZeneca; Celgene; OncoSec
Consulting or Advisory Role - New Century Health; Paragon healthcare; Welwaze
Research Funding - F. Hoffmann-La Roche Ltd, Basel, Switzerland
(OPTIONAL) Uncompensated Relationships - Roche
 
C. Marcela Diaz-Montero
No Relationships to Disclose